Prelude Capital Management’s Fractyl Health GUTS Stock Holding History

Prelude Capital Management’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,286	Closed	-$5.17K	–	1570
2026 Q1	$5.17K	Sell	11,286 -69,311	-86%	-$63.9K	﹤0.01%	1175
2025 Q4	$177K	Buy	80,597 +45,843	+132%	+$73.8K	0.01%	1089
2025 Q3	$55.3K	Buy	+34,754	New	+$45.1K	﹤0.01%	1101
2025 Q1	–	Sell	-17,401	Closed	-$35.8K	–	1575
2024 Q4	$35.8K	Buy	+17,401	New	+$40.5K	﹤0.01%	1161
2024 Q2	–	Sell	-14,567	Closed	-$108K	–	1551
2024 Q1	$108K	Buy	+14,567	New	+$123K	0.01%	1192

Other funds holding GUTS

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prelude Capital Management's GUTS Position: Q2 2026 in Review

Prelude Capital Management sold out of Fractyl Health (GUTS) in Q2 2026, closing a stake of 11,286 shares — an estimated $5.17K sold.

Prelude Capital Management first reported a position in GUTS in Q1 2024 and held it in 5 quarters. The position peaked at $177K in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

Prelude Capital Management reported no remaining Fractyl Health position as of Q2 2026 after selling out during the quarter.
Prelude Capital Management sold 11,286 Fractyl Health shares in Q2 2026, an estimated $5.17K.
Prelude Capital Management first reported a position in Fractyl Health in Q1 2024 and held it in 5 quarters.
Prelude Capital Management's Fractyl Health position peaked at $177K in Q4 2025.
77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.